Clincosm LogoSign in Get a demo

cholestasis

Showing 1 - 25 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mallampati Score, Difficult Intubation, Patient Satisfaction Trial in Buraidah

Active, not recruiting
  • Mallampati Score
  • +4 more
    • Buraidah, Qassim, Saudi Arabia
      Qassim University Medical City
    Aug 24, 2023

    FGF19 in Obstructive Cholestasis: "Unveil the Signal"

    Recruiting
    • Cholestasis
    • +4 more
    • Biospecimen sampling
    • Aachen, Germany
      RWTH Aachen
    Feb 6, 2023

    Osmotic Fragility in Red Blood Cells of Pediatric Cholestatic

    Active, not recruiting
    • Cholestasis
    • Red Cell Membrane and Enzyme Abnormalities
    • ektacytometry of red blood cells
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Oct 12, 2022

    Primary Biliary Cholangitis, Primary Biliary Cirrhosis, Cholangitis Trial in United States (HTD1801 (BUDCA))

    Completed
    • Primary Biliary Cholangitis
    • +5 more
    • HTD1801 (BUDCA)
    • Miami, Florida
    • +11 more
    Jun 24, 2022

    Cholestasis, Growth Failure Trial in Houston (SMOFlipid)

    Available
    • Cholestasis
    • Growth Failure
    • Houston, Texas
      Baylor College of Medicine / Texas Children's Hospital
    Apr 22, 2022

    Pruritus, Cholestasis, Kidney Failure Trial in Australia, New Zealand (EP547, Placebo)

    Completed
    • Pruritus
    • +2 more
    • Adelaide, South Australia, Australia
    • +3 more
    Mar 30, 2022

    Hepatitis, Autoimmune, Cholangitis, Liver Cirrhosis, Biliary Trial in Chengdu (Ursodeoxycholic acid combination of

    Recruiting
    • Hepatitis, Autoimmune
    • +3 more
    • Ursodeoxycholic acid combination of immunosuppressive agents
    • Ursodeoxycholic Acid
    • Chengdu, Sichuan, China
      West China Hospital
    Oct 26, 2021

    Cholestasis, Cholestasis of Parenteral Nutrition Trial in Houston (Omegaven)

    Completed
    Has Results
    • Cholestasis
    • Cholestasis of Parenteral Nutrition
    • Houston, Texas
    • +1 more
    May 26, 2021

    Cholestasis Trial in Worldwide (Placebo, GSK2330672)

    Completed
    Has Results
    • Cholestasis
    • Phoenix, Arizona
    • +65 more
    Apr 8, 2021

    Cholestasis Trial in San Diego (Omegaven)

    No longer available
    • Cholestasis
    • San Diego, California
    • +1 more
    Jan 7, 2021

    Cholestasis Trial in United States (Intralipid 20% I.V. Fat Emulsion)

    Completed
    Has Results
    • Cholestasis
    • Intralipid 20% I.V. Fat Emulsion
    • Aurora, Colorado
    • +4 more
    Dec 14, 2020

    Cholestasis, Parenteral Nutrition Trial in Boston (Omegaven, Intralipid)

    Completed
    • Cholestasis
    • Parenteral Nutrition
    • Boston, Massachusetts
      Childrens's Hospital Boston
    Dec 1, 2020

    About Primary Biliary Cholangitis During January 2001 to July

    Completed
    • Cholangitis
    • +5 more
      • Chengdu, Sichuan, China
        West China Hospital
      Nov 7, 2020

      Infantile Refsum's Disease, Zellweger Syndrome, Adrenoleukodystrophy Trial in Cincinnati (Cholic Acids)

      Completed
      Has Results
      • Infantile Refsum's Disease
      • +4 more
      • Cholic Acids
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Sep 28, 2020

      Cholestasis Trial in Cambridge (GSK2330672 (linerixibat), Obeticholic acid)

      Completed
      Has Results
      • Cholestasis
      • GSK2330672 (linerixibat)
      • Obeticholic acid
      • Cambridge, United Kingdom
        GSK Investigational Site
      Jul 1, 2020

      Cholestasis, Cholestasis of Parenteral Nutrition Trial in Tampa (Omegaven)

      Completed
      Has Results
      • Cholestasis
      • Cholestasis of Parenteral Nutrition
      • Tampa, Florida
        USF Health
      Jul 7, 2020

      Cholestasis Trial in London (Linerixibat tablet, [14C]-linerixibat intravenous infusion, Linerixibat oral solution)

      Completed
      Has Results
      • Cholestasis
      • Linerixibat tablet
      • +2 more
      • London, United Kingdom
        GSK Investigational Site
      May 29, 2020

      Cholestasis Trial in Cincinnati (Omegaven)

      Completed
      Has Results
      • Cholestasis
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Jun 8, 2020

      Cholestasis Trial in Los Angeles (Omegaven)

      Terminated
      Has Results
      • Cholestasis
      • Los Angeles, California
        University of California, Los Angeles
      Feb 11, 2020

      Total Parenteral Nutrition-induced Cholestasis, Cholestasis, Short Bowel Syndrome Trial in Oklahoma City (Omegaven)

      Completed
      Has Results
      • Total Parenteral Nutrition-induced Cholestasis
      • +6 more
      • Oklahoma City, Oklahoma
        OU Children's Hospital
      Nov 19, 2019

      Pancreatic Tumors, Cholestasis Trial in Germany, United States (nab-paclitaxel, Gemcitabine)

      Terminated
      • Pancreatic Neoplasms
      • Cholestasis
      • Scottsdale, Arizona
      • +5 more
      Oct 30, 2019

      Parenteral Nutrition Associated Liver Disease PNALD, Cholestasis Trial in Omaha (Omegaven™)

      Completed
      Has Results
      • Parenteral Nutrition Associated Liver Disease PNALD
      • Cholestasis
      • Omaha, Nebraska
        University of Nebraska Medical Center
      Oct 4, 2019

      Paternally Inherited Phenotypes in Cholestasis

      Unknown status
      • Cholestasis
      • +2 more
      • Questionnaire, semen sample, fasting blood sample
      • +2 more
      • London, United Kingdom
      • +1 more
      Aug 1, 2019

      Cholestasis, Short Bowel Syndrome Trial in Philadelphia (Omegaven)

      Approved for marketing
      • Cholestasis
      • Short Bowel Syndrome
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Apr 10, 2019

      Cholestasis, Total Parenteral Nutrition-induced Cholestasis Trial in Chicago (Omegaven)

      Approved for marketing
      • Cholestasis
      • Total Parenteral Nutrition-induced Cholestasis
      • Chicago, Illinois
        Rush University Medical Center
      Apr 4, 2019